Phase II Trial in Subjects with Allergic Asthma Completes Enrolment

29th Sep 11

Release Date: 29/09/2011 12:00am

Pharmaxis today announced it has completed enrolment of all subjects into its Phase II clinical trial evaluating ASM8, a potential new treatment for patients with moderate to severe asthma.


Read full media release - pdf

Categories: News and Media